216 related articles for article (PubMed ID: 11433023)
1. Significantly higher activity of a cytoplasmic hammerhead ribozyme than a corresponding nuclear counterpart: engineered tRNAs with an extended 3' end can be exported efficiently and specifically to the cytoplasm in mammalian cells.
Kuwabara T; Warashina M; Koseki S; Sano M; Ohkawa J; Nakayama K; Taira K
Nucleic Acids Res; 2001 Jul; 29(13):2780-8. PubMed ID: 11433023
[TBL] [Abstract][Full Text] [Related]
2. Construction of a ribozyme-expression system that effectively transports ribozymes to the cytoplasm.
Sano M; Kuwabara T; Nara Y; Warashina M; Taira K
Nucleic Acids Symp Ser; 2000; (44):203-4. PubMed ID: 12903339
[TBL] [Abstract][Full Text] [Related]
3. Transport of intracellularly active ribozymes to the cytoplasm.
Miyagishi M; Kuwabara T; Taira K
Cancer Chemother Pharmacol; 2001 Aug; 48 Suppl 1():S96-101. PubMed ID: 11587376
[TBL] [Abstract][Full Text] [Related]
4. Ribozyme expression systems.
Sano M; Taira K
Methods Mol Biol; 2004; 252():195-207. PubMed ID: 15017050
[TBL] [Abstract][Full Text] [Related]
5. Recognition of engineered tRNAs with an extended 3' end by Exportin-t (Xpo-t) and transport of tRNA-attached ribozymes to the cytoplasm in somatic cells.
Kuwabara T; Warashina M; Sano M; Tang H; Wong-Staal F; Munekata E; Taira K
Biomacromolecules; 2001; 2(4):1229-42. PubMed ID: 11777397
[TBL] [Abstract][Full Text] [Related]
6. Relationships between the activities in vitro and in vivo of various kinds of ribozyme and their intracellular localization in mammalian cells.
Kato Y; Kuwabara T; Warashina M; Toda H; Taira K
J Biol Chem; 2001 May; 276(18):15378-85. PubMed ID: 11278700
[TBL] [Abstract][Full Text] [Related]
7. Factors governing the activity in vivo of ribozymes transcribed by RNA polymerase III.
Koseki S; Tanabe T; Tani K; Asano S; Shioda T; Nagai Y; Shimada T; Ohkawa J; Taira K
J Virol; 1999 Mar; 73(3):1868-77. PubMed ID: 9971765
[TBL] [Abstract][Full Text] [Related]
8. Short hairpin type of dsRNAs that are controlled by tRNA(Val) promoter significantly induce RNAi-mediated gene silencing in the cytoplasm of human cells.
Kawasaki H; Taira K
Nucleic Acids Res; 2003 Jan; 31(2):700-7. PubMed ID: 12527779
[TBL] [Abstract][Full Text] [Related]
9. Formation of a catalytically active dimer by tRNA(Val)-driven short ribozymes.
Kuwabara T; Warashina M; Orita M; Koseki S; Ohkawa J; Taira K
Nat Biotechnol; 1998 Oct; 16(10):961-5. PubMed ID: 9788354
[TBL] [Abstract][Full Text] [Related]
10. The expression cassette determines the functional activity of ribozymes in mammalian cells by controlling their intracellular localization.
Bertrand E; Castanotto D; Zhou C; Carbonnelle C; Lee NS; Good P; Chatterjee S; Grange T; Pictet R; Kohn D; Engelke D; Rossi JJ
RNA; 1997 Jan; 3(1):75-88. PubMed ID: 8990401
[TBL] [Abstract][Full Text] [Related]
11. Improved accumulation and activity of ribozymes expressed from a tRNA-based RNA polymerase III promoter.
Thompson JD; Ayers DF; Malmstrom TA; McKenzie TL; Ganousis L; Chowrira BM; Couture L; Stinchcomb DT
Nucleic Acids Res; 1995 Jun; 23(12):2259-68. PubMed ID: 7610054
[TBL] [Abstract][Full Text] [Related]
12. Use of a nonviral vector to express a chimeric tRNA-ribozyme against lymphocytic choriomeningitis virus: cytoplasmic accumulation of a catalytically competent transcript but minimal antiviral effect.
Gebhard JR; Perry CM; Mahadeviah S; Whitton JL
Antisense Nucleic Acid Drug Dev; 1997 Feb; 7(1):3-11. PubMed ID: 9055033
[TBL] [Abstract][Full Text] [Related]
13. Use of ribozymes in cellular aging research.
Deocaris CC; Kaul SC; Wadhwa R
Methods Mol Biol; 2007; 371():209-26. PubMed ID: 17634584
[TBL] [Abstract][Full Text] [Related]
14. Transcripts containing a small anti-HIV hammerhead ribozyme that are active in the cell cytoplasm but inactive in vitro as free RNAs.
Domi A; Beaud G; Favre A
Biochimie; 1996; 78(7):654-62. PubMed ID: 8955908
[TBL] [Abstract][Full Text] [Related]
15. Retroviral vectors designed for targeted expression of RNA polymerase III-driven transcripts: a comparative study.
Ilves H; Barske C; Junker U; Böhnlein E; Veres G
Gene; 1996 Jun; 171(2):203-8. PubMed ID: 8666273
[TBL] [Abstract][Full Text] [Related]
16. Ribozyme mediated destruction of RNA in vivo.
Cotten M; Birnstiel ML
EMBO J; 1989 Dec; 8(12):3861-6. PubMed ID: 2684648
[TBL] [Abstract][Full Text] [Related]
17. Activities of tRNA-embedded dimeric minizymes.
Kuwabara T; Warashina M; Nakayama A; Ohkawa J; Taira K
Nucleic Acids Symp Ser; 1997; (37):307-8. PubMed ID: 9586122
[TBL] [Abstract][Full Text] [Related]
18. Design, characterization and testing of tRNA3Lys-based hammerhead ribozymes.
Medina MF; Joshi S
Nucleic Acids Res; 1999 Apr; 27(7):1698-708. PubMed ID: 10076002
[TBL] [Abstract][Full Text] [Related]
19. Enhanced expression and HIV-1 inhibition of chimeric tRNA(Lys3)-ribozymes under dual U6 snRNA and tRNA promoters.
Chang Z; Westaway S; Li S; Zaia JA; Rossi JJ; Scherer LJ
Mol Ther; 2002 Oct; 6(4):481-9. PubMed ID: 12377189
[TBL] [Abstract][Full Text] [Related]
20. Novel method for selection of tRNA-driven ribozymes with enhanced stability in mammalian cells.
Sano M; Kuwabara T; Warashina M; Fukamizu A; Taira K
Antisense Nucleic Acid Drug Dev; 2002 Oct; 12(5):341-52. PubMed ID: 12477283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
